Neural mechanisms of early postinflammatory dysmotility in rat small intestine.
Although human postinflammatory dysmotility is known, so far animal studies have primarily investigated changes during inflammation. Here, we focused on postinflammatory changes in rat jejunal myenteric plexus and jejunal motility. Evolution of ethanol/2,4,6-tri-nitrobenzene sulphonic acid (TNBS)-induced inflammation was assessed histologically and by measuring myeloperoxidase activity (MPO). Electromyography and immunohistochemistry were performed 1 week after ethanol/TNBS and also after N(G)-nitro-L-arginine methyl ester (L-NAME) administration. Ethanol/TNBS induced a transient inflammation, with normalization of MPO and histological signs of an early phase of recovery after 1 week. The number of cholinergic neurones was not altered, but myenteric neuronal nitric oxide synthase (nNOS)-immunoreactivity was significantly lower in the early phase of recovery after TNBS compared with water (1.8 +/- 0.2 vs 3.5 +/- 0.2 neurones ganglion(-1), P < 0.001). Interdigestive motility was disrupted with a loss of phase 1 quiescence, an increase of migrating myoelectric complex cycle length, a higher number of non-propagated activity fronts and a decrease of adequately propagated phase 3 s after TNBS. Administration of L-NAME resulted in a similar disruption of interdigestive motility patterns. In the early phase of recovery after ethanol/TNBS-induced jejunal inflammation, a loss of motor inhibition occurs due to a decrease of myenteric nNOS activity. These observations may provide a model for early postinflammatory dysmotility syndromes.
Demedts
I
I
Center for Gastroenterological Research, Catholic University Leuven, Leuven, Belgium.
Geboes
K
K
Kindt
S
S
Vanden Berghe
P
P
Andrioli
A
A
Janssens
J
J
Tack
J
J
D000818:Animals; D004576:Electromyography; D004751:Enteritis / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004801:Eosine Yellowish-(YS); D005769:Gastrointestinal Motility / Q000502:physiology*; D006416:Hematoxylin; D007583:Jejunum / Q000276:immunology / Q000294:innervation* / Q000473:pathology; D008297:Male; D009197:Myenteric Plexus / Q000502:physiology*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013194:Staining and Labeling
D004791:Enzyme Inhibitors; D009569:Nitric Oxide; D009195:Peroxidase; D004801:Eosine Yellowish-(YS); D019331:NG-Nitroarginine Methyl Ester; D006416:Hematoxylin